Research Solutions RSSS Q1 2026 Earnings Miss EPS 003 vs 004 Expected Flaherty Crumrine Preferred and Income Fund PFD Edges Higher Within Established Range Endurance Technologies IPO Opens for Subscription Key Details and Market Implications Mazda Leverages Flagship CX5 SUV to Drive Sales Growth Amid Intensifying Competition from Chinese Automakers Scientists Pursue Specialized Exercise Equipment for Future Spaceflight Missions China Emerges as Top Competitor in Humanoid Robot Race Tesla CEO Elon Musk Says Singapores STI Inches Up 002 as Gainers Outpace Losers Amid Mixed Regional Markets Chime CHYM Reports 647M Revenue in Q1 2026 Marks First GAAP Profitable Quarter AIRelated Layoffs May Not Guarantee Stock Gains Data Suggests Citi Raises Micron Technology Price Target to 840 Citing DRAM Price Surge IMMR Q3 2025 Earnings EPS Surges Past Estimates Stock Rises on Strong Licensing Performance Serve Robotics SERV Q1 2026 Earnings WiderThanExpected Losses Highlight Cost Pressures C4 Therapeutics CCCC Q1 2026 Earnings Narrowing Losses Drive Surprise Beat Despite Zero Revenue OXLCO Q4 2025 Earnings Mixed Results as EPS Misses Estimates Amid Stable Fund Performance Mesoblast Q1 2026 Earnings Narrower Loss Surprises on Cost Discipline Stock Gains Transocean RIG Slides 5 as Offshore Drilling Sector Faces Renewed Headwinds EMCOR Group EME Rises 17 Resistance Test Looms as Momentum Builds Sila Realty Trust SILA Holds Steady Near 3020 Testing Key Support and Resistance Levels ConocoPhillips COP Holds Steady Near 120 as Support and Resistance Levels Come Into Focus US Treasury Yields Fall but ING Sees Upward Pressure on LongEnd Yields HAE Q1 2026 Earnings EPS Slightly Beats Estimates Shares Edge Higher Dream Finders Homes Inc DFH Q1 2026 Earnings EPS Miss and Stock Decline Amid Housing Market Headwinds iQIYI Q1 2026 Earnings EPS Misses Estimates as Stock Declines 182 MCHB Q1 2026 Earnings Profit Miss Sends Shares Lower Amid Margin Pressures Reviva Pharmaceuticals RVPH Q1 2026 Earnings NarrowerthanExpected Loss Highlights Cost Discipline Amid PreRevenue Stage Milestone Pharmaceuticals MIST Q1 2026 Earnings Significant EPS Miss as PreRevenue Biotech Continues Pipeline Development Vera Therapeutics Q1 2026 Earnings EPS Miss Highlights PreRevenue Stage Challenges BXP Q1 2026 Earnings Strong EPS Surprise Driven by Operational Efficiency